SCHEMBL19385802

SCHEMBL19385802

NC1(c2ncccn2)CCC1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.36
AKT1 P31749 4/20 0.35
AKT2 P31751 1/20 0.34
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246118 0.90 HSP90AA1 (0.36) PARP1HSP90AA1
Hydrochloric Acid SCHEMBL2392462 0.87 HSP90AA1 (0.35) PARP1HSP90AA1
Hydrochloric Acid SCHEMBL667557 0.87 HSP90AA1 (0.35) PARP1HSP90AA1
SCHEMBL28475743 0.78 OPRL1 (0.35)
SCHEMBL19410888 0.76
Hydrochloric Acid SCHEMBL16113787 0.76 OPRL1 (0.34)
SCHEMBL19428135 0.75 HTT (0.31) AKT1AKT2
SCHEMBL16597568 0.74 GRIN1 (0.31) HSP90AA1
SCHEMBL15285749 0.73 HDAC8 (0.32) HSP90AA1
Hydrochloric Acid SCHEMBL19410899 0.73 HTT (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110461842-A FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB BIOPHARMA SPRL 2019-11-15 CN disclosed
CN-109219608-A FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB生物制药私人有限公司 2019-01-15 CN disclosed
CN-109219609-A FUSED HEXACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB生物制药私人有限公司 2019-01-15 CN disclosed
CN-109195969-A FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB生物制药私人有限公司 2019-01-11 CN disclosed
CN-109195968-A FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB生物制药私人有限公司 2019-01-11 CN disclosed
WO-2017165233-A1 BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-28 WO disclosed